Citigroup’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.31M | Sell |
146,525
-205,658
| -58% | -$1.84M | ﹤0.01% | 2346 |
|
2025
Q1 | $2.64M | Buy |
352,183
+75,481
| +27% | +$566K | ﹤0.01% | 1863 |
|
2024
Q4 | $2.08M | Buy |
276,702
+123,779
| +81% | +$931K | ﹤0.01% | 2104 |
|
2024
Q3 | $1.16M | Buy |
152,923
+35,978
| +31% | +$273K | ﹤0.01% | 2449 |
|
2024
Q2 | $723K | Sell |
116,945
-2,157,830
| -95% | -$13.3M | ﹤0.01% | 2461 |
|
2024
Q1 | $11.6M | Buy |
2,274,775
+1,080,811
| +91% | +$5.49M | 0.01% | 835 |
|
2023
Q4 | $7.15M | Buy |
1,193,964
+822,092
| +221% | +$4.92M | 0.01% | 965 |
|
2023
Q3 | $2.63M | Buy |
371,872
+19,329
| +5% | +$137K | ﹤0.01% | 1334 |
|
2023
Q2 | $2.48M | Sell |
352,543
-306,924
| -47% | -$2.16M | ﹤0.01% | 1523 |
|
2023
Q1 | $5.5M | Buy |
659,467
+318,249
| +93% | +$2.65M | ﹤0.01% | 1082 |
|
2022
Q4 | $3.92M | Sell |
341,218
-133,361
| -28% | -$1.53M | ﹤0.01% | 1160 |
|
2022
Q3 | $5.98M | Buy |
474,579
+68,691
| +17% | +$866K | ﹤0.01% | 1037 |
|
2022
Q2 | $4.29M | Buy |
405,888
+338,824
| +505% | +$3.58M | ﹤0.01% | 1189 |
|
2022
Q1 | $1.09M | Sell |
67,064
-321,814
| -83% | -$5.24M | ﹤0.01% | 2265 |
|
2021
Q4 | $5.39M | Buy |
388,878
+226,689
| +140% | +$3.14M | ﹤0.01% | 1239 |
|
2021
Q3 | $2.33M | Sell |
162,189
-139,625
| -46% | -$2.01M | ﹤0.01% | 1795 |
|
2021
Q2 | $4.77M | Sell |
301,814
-60,351
| -17% | -$954K | ﹤0.01% | 1449 |
|
2021
Q1 | $3.68M | Buy |
362,165
+287,904
| +388% | +$2.93M | ﹤0.01% | 1547 |
|
2020
Q4 | $554K | Buy |
74,261
+4,069
| +6% | +$30.4K | ﹤0.01% | 2567 |
|
2020
Q3 | $242K | Sell |
70,192
-241,510
| -77% | -$833K | ﹤0.01% | 2684 |
|
2020
Q2 | $1.49M | Buy |
311,702
+167,233
| +116% | +$797K | ﹤0.01% | 1830 |
|
2020
Q1 | $288K | Sell |
144,469
-55,046
| -28% | -$110K | ﹤0.01% | 2633 |
|
2019
Q4 | $688K | Sell |
199,515
-165,838
| -45% | -$572K | ﹤0.01% | 2440 |
|
2019
Q3 | $1.05M | Sell |
365,353
-14,295
| -4% | -$41K | ﹤0.01% | 2086 |
|
2019
Q2 | $1.44M | Buy |
379,648
+352,727
| +1,310% | +$1.34M | ﹤0.01% | 1874 |
|
2019
Q1 | $219K | Sell |
26,921
-213,395
| -89% | -$1.74M | ﹤0.01% | 3066 |
|
2018
Q4 | $1.94M | Buy |
240,316
+115,418
| +92% | +$932K | ﹤0.01% | 1556 |
|
2018
Q3 | $953K | Buy |
124,898
+39,265
| +46% | +$300K | ﹤0.01% | 2040 |
|
2018
Q2 | $491K | Sell |
85,633
-53,069
| -38% | -$304K | ﹤0.01% | 2370 |
|
2018
Q1 | $662K | Sell |
138,702
-16,879
| -11% | -$80.6K | ﹤0.01% | 2116 |
|
2017
Q4 | $764K | Buy |
155,581
+127,326
| +451% | +$625K | ﹤0.01% | 2057 |
|
2017
Q3 | $148K | Sell |
28,255
-43,226
| -60% | -$226K | ﹤0.01% | 3132 |
|
2017
Q2 | $398K | Buy |
71,481
+68,141
| +2,040% | +$379K | ﹤0.01% | 2558 |
|
2017
Q1 | $28K | Sell |
3,340
-23,851
| -88% | -$200K | ﹤0.01% | 3941 |
|
2016
Q4 | $172K | Buy |
27,191
+25,050
| +1,170% | +$158K | ﹤0.01% | 3652 |
|
2016
Q3 | $10K | Sell |
2,141
-19,297
| -90% | -$90.1K | ﹤0.01% | 4435 |
|
2016
Q2 | $61K | Sell |
21,438
-34,026
| -61% | -$96.8K | ﹤0.01% | 3594 |
|
2016
Q1 | $157K | Buy |
55,464
+30,629
| +123% | +$86.7K | ﹤0.01% | 3662 |
|
2015
Q4 | $257K | Sell |
24,835
-36,872
| -60% | -$382K | ﹤0.01% | 2867 |
|
2015
Q3 | $703K | Buy |
61,707
+33,339
| +118% | +$380K | ﹤0.01% | 1966 |
|
2015
Q2 | $423K | Sell |
28,368
-3,306
| -10% | -$49.3K | ﹤0.01% | 2259 |
|
2015
Q1 | $286K | Sell |
31,674
-235
| -0.7% | -$2.12K | ﹤0.01% | 2669 |
|
2014
Q4 | $389K | Buy |
31,909
+24,910
| +356% | +$304K | ﹤0.01% | 2647 |
|
2014
Q3 | $68K | Sell |
6,999
-1,975
| -22% | -$19.2K | ﹤0.01% | 3443 |
|
2014
Q2 | $115K | Buy |
8,974
+371
| +4% | +$4.75K | ﹤0.01% | 2988 |
|
2014
Q1 | $91K | Buy |
8,603
+2,035
| +31% | +$21.5K | ﹤0.01% | 3563 |
|
2013
Q4 | $50K | Buy |
6,568
+4,527
| +222% | +$34.5K | ﹤0.01% | 4160 |
|
2013
Q3 | $15K | Sell |
2,041
-149
| -7% | -$1.1K | ﹤0.01% | 4406 |
|
2013
Q2 | $3K | Buy |
+2,190
| New | +$3K | ﹤0.01% | 4795 |
|